High-risk brainstem tumours are completely resected

Recently, the chief surgeon of the Department of Neurosurgery Ye Jin of the People's Hospital of Guangxi Zhuang Autonomous Region led the team for 7 hours to successfully remove a brain stem tumor with a diameter of about 0.5 cm.

The 36-year-old patient Wang had a sudden left eye strabismus at the beginning of January and had occasional ghosting. He was admitted to the hospital for head magnetic resonance imaging. He was referred to as brain stem hemorrhage, but the lesion was confined. Because there was no other discomfort, the outpatient doctor followed the examination. He will go home. In early February, the patient developed numbness of the right face, trunk, and limbs, and his sensation was diminished, accompanied by dizziness. The head magnetic resonance was re-examined to find that the brainstem's bleeding range expanded. The doctor discussed the condition of the disease and thought that it was brain stem tumor with hemorrhage. Although the hemorrhage was temporarily limited, if it is allowed to develop, the tumor is likely to increase or rebleed, resulting in life-threatening.

Ye Jin repeatedly communicated with Mr. Wang and his family and hoped they had a full understanding of the condition and operation. This operation is very difficult and extremely dangerous. The family members think twice and discuss it over and over again. Finally, they decide to "fight one." After perfect preoperative preparation, Ye Jin successfully removed the tumor under a microscope with his skilled neurosurgical technique. During the operation, see the dark red old hematoma below the brain tissue at the junction of the left pontine bulbar plexus. After clearing the hematoma, the tumor is located in it. Ye Jin carefully separates the tumor boundary, and it is almost a breath-hold operation. The blood vessels, cranial nerves, and brain stem The tissues were well protected and the patient's vital signs such as heartbeat, respiration, and blood pressure were stable during the operation. After surgery, the tumor pathology was consistent with hemangioma. All the excisions were performed during the operation, and no adjuvant therapy such as radiotherapy and chemotherapy was required. (Reporter Tan Dejun correspondent Huang Rui)


Extract Powder

China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer

Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.apipepdites.com

Posted on